Filoviruses get their name from the Latin word "filum," meaning thread—a reference to their long, filamentous shape. This ...
Zacks Investment Research on MSN
MRNA to get CEPI funding for Phase III study on pandemic influenza jab
Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in ...
The Aam Aadmi Party (AAP) on Thursday announced that it will contest the upcoming BMC Elections 2026 independently, fielding candidates in all 227 wards ...
With civic polls nearing, Model Code of Conduct sets strict limits on government actions, welfare schemes and postings ahead ...
Sanofi ( ($SNY) ) just unveiled an update. In December 2025, Sanofi announced the completion of its acquisition of Vicebio Ltd, which enhances its ...
Bhopal (Madhya Pradesh): Madhya Pradesh saw five distinct viral waves in 2025, an unusual pattern compared to the typical ...
TikTok, X, and Instagram are flooded with videos about a mysterious “2025 throat virus” that’s making everyone sick. The ...
Sanofi (NASDAQ:SNY) is one of the best pharma stocks to invest in. Sanofi (NASDAQ:SNY) was downgraded to Neutral from ...
We used Finviz to compile a list of the best pharma stocks and selected the top 11 with the highest number of hedge fund ...
Paris: French multinational pharmaceutical giant, Sanofi, has announced the completion of its acquisition of Vicebio Ltd.This ...
Sanofi, an R&D driven, AI-powered biopharma company, announces the completion of its acquisition of Vicebio Ltd (Vicebio). This acquisition brings an early-stage combination vaccine candidate for ...
Sanofi completes acquisition of VicebioParis, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback